Part 7: Acid-Base Disorders

33: Respiratory Acid-Base Disorders

 

Chapter outlines

RESPIRATORY ACIDOSIS
Definition and basic understanding
Renal compensation
Respiratory acidosis vs. metabolic alkalosis
Relation between hypercapnia and hypoxemia
Etiology
Clinical features
Diagnosis
History
Physical examination
Investigations
Treatment
General measures
Oxygen therapy
Ventilatory support
Alkali therapy
RESPIRATORY ALKALOSIS
Definition and basic understanding
Renal compensation
Etiology
Clinical features
Diagnosis
Treatment
Respiratory acidosis and respiratory alkalosis are the two primary respiratory acid-base disorders commonly encountered in clinical practice, both resulting from primary changes in pCO2 due to various disorders.

RESPIRATORY ACIDOSIS

Definition

Respiratory acidosis, also known as primary hypercapnia, is a clinical disorder characterized by a primary elevation in the PaCO2 (>45 mmHg) leading to a reduction in pH (<7.35) and variable compensatory increase in the plasma HCO3 concentration.
Respiratory acidosis occurs when the effective alveolar ventilation (CO2 excretion by the lung) fails to keep pace with the rate of CO2 production. Acute respiratory acidosis occurs rapidly within <48 hours, while chronic respiratory acidosis develops slowly over days to weeks (>48 hours).

Renal (metabolic) compensation

Respiratory acidosis leads to renal compensation through increased urinary H+ secretion, resulting in acidic urine. This gradual process leads to a rise in plasma HCO3 levels, mitigating acidosis. Because renal compensation is a slow process, the compensatory increase in HCO3 is small in acute respiratory acidosis. In contrast, in chronic respiratory acidosis, the compensatory rise in HCO3 is more substantial over time due to robust and prolonged renal compensation.
Acute respiratory acidosis: Every 10 mm of Hg rise in PaCO2 causes 1 mEq/L rise in HCO3 and 0.1 fall in pH.
Chronic respiratory acidosis: Every 10 mm Hg rise in PaCO2 causes a 4 mEq/L rise in HCO3 and a 0.03 fall in pH.
Serum HCO3 usually does not exceed 38 mEq/L due to compensation. If HCO3 is >38 mEq/L, think of concomitant metabolic alkalosis.

REFERENCES

  1. Sarkar M, Niranjan N, Banyal PK. Mechanisms of hypoxemia. Lung India. 2017;34(1):47–60.
  2. Palmer BF, Clegg DJ. Respiratory Acidosis and Respiratory Alkalosis: Core Curriculum 2023. Am J Kidney Dis. 2023;82(3):347–359.
  3. Adrogué HJ, Madias NE. Management of Life-Threatening Acid–Base Disorders. N Engl J Med. 1998;338(1):26–34.
  4. Boatright JE, Jensen MQ. Therapeutic Gases: Management and Administration. In: Hess DR, MacIntyre NR, Galvin WF, editors. Respiratory Care: Principles and Practice, 4th edition. Jones & Bartlett Learning, LLC, an Ascend Learning Company; 2021. Chapter 14, pages 285–320.
  5. Theerawit P, Soipetkasem P. An importance of respiratory drive and effort during mechanical ventilation: Respiratory drive and effort in respiratory failure. Clin Crit Care [Internet]. 2023;31(1):2023:e0001.
  6. Rocker G. Harms of over oxygenation in patients with exacerbation of chronic obstructive pulmonary disease. CMAJ. 2017;189(22):E762–E763.
  7. Sarkar M, Madabhavi I, Kadakol N. Oxygen-induced hypercapnia: physiological mechanisms and clinical implications. Monaldi Arch Chest Dis. 2023;93(3):2399.
  8. O’Driscoll BR, Howard LS, Earis J, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax 2017;72(Suppl 1):ii1–ii90.
  9. Echevarria C, Steer J, Wason J, et al. Oxygen therapy and inpatient mortality in COPD exacerbation. Emerg Med J. 2021;38(3):170–7.
  10. Barnett A, Beasley R, Buchan C, et al. Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’. Respirology. 2022;27(4):262–276.
  11. Fujishima S. Guideline-based management of acute respiratory failure and acute respiratory distress syndrome. J Intensive Care. 2023;11(1):10.
  12. Austin MA, Wills KE, Blizzard L, et al. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomized controlled trial. BMJ 2010;341:c5462.
  13. Adrogué HJ, Madias NE. Alkali Therapy for Respiratory Acidosis: A Medical Controversy. Am J Kidney Dis. 2020;75(2):265–271.
  14. Chand R, Swenson ER, Goldfarb DS. Sodium bicarbonate therapy for acute respiratory acidosis. Curr Opin Nephrol Hypertens. 2021;30(2):223–230.
  15. Quade BN, Parker MD, Occhipinti R. The therapeutic importance of acid-base balance. Biochem Pharmacol. 2021;183:114278.
  16. Sanghavi S, Albert TJ, Swenson ER. ACID-BASE BALANCE. In: Broaddus VC, Ernst JD, King TE Jr, editors. Murray & Nadel’s Textbook of Respiratory Medicine. Seventh Edition. Elsevier - Health Sciences Division; 2021. Chapter 12, page 166.
  17. Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002;347(1):43–53.
  18. Mazzara JT, Ayres SM, Grace WJ. Extreme hypocapnia in the critically ill patient. Am J Med. 1974;56(4):450–6.
  19. Foster GT, Varizi ND, Sassoon CS. Respiratory alkalosis. Respir Care. 2001;46(4):384–91.
  20. Callaham M. Hypoxic hazards of traditional paper bag rebreathing in hyperventilating patients. Ann Emerg Med 1989;18(6):622–8.
  21. Burtscher M, Gatterer H, Faulhaber M, et al. Acetazolamide pre-treatment before ascending to high altitudes: when to start? Int J Clin Exp Med. 2014;7(11):4378–83.
TABLE OF CONTENTS